Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255190 · ClinicalTrials.gov registry record · Phase 3
Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 591
- Enrollment target
NCT00255190 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 591 participants.
The verdict
NCT00255190, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 591 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the long-term safety profile of daily treatment with dexlansoprazole MR in subjects with gastroesophageal reflux disease.
Interventions
- DRUG Dexlansoprazole MR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 591 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00255190
The ClinicalTrials.gov registry entry for NCT00255190 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 591 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexlansoprazole MR is the first listed.
NCT00255190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00255190 about?
NCT00255190 is a clinical study titled "Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn". The purpose of this study is to determine the long-term safety profile of daily treatment with dexlansoprazole MR in subjects with gastroesophageal reflux disease.
What is the current status of trial NCT00255190?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 591 participants. The study started on 2006-01. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00255190?
The interventions under investigation include: Dexlansoprazole MR (DRUG).
Who is sponsoring clinical trial NCT00255190?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.